Table 1. Patient baseline... | American Society of Hematology

Table 1.

Patient baseline characteristics

Patient	Age, at time of transplantation, y/sex	Pretransplantation EDSS	Type of MS	Duration MS from diagnosis, y/duration progressive MS, y
1	43/F	8.0	SPMS	3.5/2.5
2	34/F	8.5	SPMS	14/8
3	35/F	7.0	PRMS	15/15
4	40/M	8.0	PRMS	4/4
5	44/F	8.0	SPMS	4/2
6	21/F	8.0	SPMS	3/^*
7	34/F	6.5	SPMS	5/^*
8	47/M	7.0	SPMS	7/^*
9	52/M	7.5	SPMS	11/4
10	44/F	3.0	PRMS	2/1
11	24/M	3.5	PRMS	2/2
12	40/M	7.0	SPMS	7/2
13	40/M	7.0	SPMS	7/3
14	47/F	5.5	SPMS	16/3
15	52/M	6.0	SPMS	18/4
16	29/M	3.5	RRMS	9 months
17	28/M	5.5	PRMS	5/1
18	28/M	7.0	PRMS	10/^*
19	45/F	6.0	SPMS	14/3
20	38/M	5.0	SPMS	4/^*
21	51/F	6.0	SPMS	12/^*

Patient	Age, at time of transplantation, y/sex	Pretransplantation EDSS	Type of MS	Duration MS from diagnosis, y/duration progressive MS, y
1	43/F	8.0	SPMS	3.5/2.5
2	34/F	8.5	SPMS	14/8
3	35/F	7.0	PRMS	15/15
4	40/M	8.0	PRMS	4/4
5	44/F	8.0	SPMS	4/2
6	21/F	8.0	SPMS	3/^*
7	34/F	6.5	SPMS	5/^*
8	47/M	7.0	SPMS	7/^*
9	52/M	7.5	SPMS	11/4
10	44/F	3.0	PRMS	2/1
11	24/M	3.5	PRMS	2/2
12	40/M	7.0	SPMS	7/2
13	40/M	7.0	SPMS	7/3
14	47/F	5.5	SPMS	16/3
15	52/M	6.0	SPMS	18/4
16	29/M	3.5	RRMS	9 months
17	28/M	5.5	PRMS	5/1
18	28/M	7.0	PRMS	10/^*
19	45/F	6.0	SPMS	14/3
20	38/M	5.0	SPMS	4/^*
21	51/F	6.0	SPMS	12/^*

Patients listed by order of enrollment on study.

y indicates years; MS, multiple sclerosis; SPMS, secondary progressive multiple sclerosis; PRMS, progressive relapsing multiple sclerosis; and RRMS, relapsing-remitting multiple sclerosis.

Duration of progressive disease could not be accurately determined from medical records.

View Large

This Feature Is Available To Subscribers Only